News Center
Shanghai Pharma Listed on "Top 500 Enterprises of China" Again

On September 11th, China Enterprise Confederation and China Enterprise Directors Association released the list of "Top 500 Enterprises of China 2017" and the list of "Top 500 Manufacturing Enterprises of China 2017". Shanghai Pharma made its mark on both lists, continuing its leading position in the industry. Other rankings including "Top 500 Service Enterprises of China 2017" were also released on the day.

According to incomplete statistics, about 30 pharmaceutical companies are found on three of the "Top 500" lists, including 12 on "Top 500 Enterprises of China 2017", among which Shanghai Pharma ranked the 2nd; and 20 on "Top 500 Manufacturing Enterprises of China 2017", among which Shanghai Pharma ranked top.

By the criteria of operating income of 2016, the expert committee is entitled to evaluate and approve the finalists of "Top 500 Enterprises of China 2017", threshold being set at 28 billion and 311 million yuan. Shanghai Pharma continued to maintain the leading position, ranking 134th on "Top 500 Enterprises of China 2017" with an operating income of 120,764.66 million yuan, and 45th on "Top 500 Manufacturing Enterprises of China 2017".

In recent years, Shanghai Pharma has been integrating core resources of the industry chain and constantly optimizing the industrial distribution, demonstrating a strong growth of business scale. In the first half of this year, the company's growth of industrial income hit a new record, and gained phased achievements on a number of researches. In the future, Shanghai Pharma will actively seize national strategic opportunities, conform to industry trends, and integrate with corporate development strategies. Taking health industry as the main line, and innovation development, intensive development, international development, and industry-finance integrated development as the driving forces, it will build the international vision and pattern, ensure of the leading position in the domestic pharmaceutical industry, and strive to ascend on "Global 500" during the "13th Five-Year Plan" period.

 

The subject of concern
Produced By 大汉网络 大汉版通发布系统